Table 1 |
|
|
Features of TSE diseases for which the RuNAway model may provide an explanation |
|
|
TSE Feature |
Explanation afforded by RuNAway |
|
|
|
|
Endogenous origin of TSE |
SINEs are endogenous |
|
TSE Agent becomes infectious |
TSE causing SINE is mutated for enhanced replication |
|
and virulence |
|
|
Long latency |
RT-mediated SINE gene proliferation is a slow |
|
process. Spreading between cells is much less efficient |
|
|
than viral infection |
|
|
Shorter visible disease period |
Transition to aggressive second RuNAway cycle |
|
Inheritance of TSE strain |
SINEs are nucleic acid and obey the laws of genetics |
|
variation |
and inheritance |
|
Species barrier to infection |
Adaptation to new RNA primer sequence required in |
|
new host species |
|
|
Absence of immune reaction |
SINEs are nucleic acid and therefore not immunogenic |
|
PrP protein required for |
When overproduced, PrP protein is prone to form |
|
pathology |
aggregates which damage neighbouring cells |
|
Agent causes PrPSc precipitation |
SINEs can inhibit PKR a negative regulator of |
|
translation, leading to overproduction of PrP protein |
|
|
and deposition of amyloid plaques |
|
|
PrP0/0 mouse does not succumb |
PrP0/0 mouse is infected by scrapie SINEs but without |
|
to scrapie |
PrP expression no amyloid plaques can form |
|
PrP0/0 mouse transmits scrapie |
TSE SINE replicates in PrP0/0 mouse cells |
|
agent |
|
|
PrP0/0 mouse transmits scrapie |
TSE SINE replication is dependent on SINE RNA |
|
agent less efficiently than |
synthesis which is not stress-induced in the absence of |
|
wildtype mouse |
second RuNAway cycle |
|
|
|
|
Gibson Genome Biology 2001 2:preprint0006.1 doi:10.1186/gb-2001-2-7-preprint0006 |
|